Synaptic Systems (SynSys)


At a Glance
  • Status: Completed Consortium
  • Year Launched: 2010
  • Initiating Organization: European Commission Seventh Framework Programme (FP7)
  • Initiator Type: Government
  • No disease focus
  • Location: Europe

Abstract

Synaptic Systems (SynSys) aims at molecular analysis of synapse function and dynamic modeling. The perspective is to generate a blueprint for the discovery of novel pathways and targets that enable rational strategies to design therapies for human brain disease.

Mission

SynSys features a closed loop from data integration and modeling, human genetics, physiology, proteomics, and the application of engineered model systems to test model predictions. The main objectives of this project are as follows:

Consortium History

July 1, 2010: Project started

Financing

SynSys is funded through the European Union Seventh Framework Programme.

Points of Contact

Sylics (the trade name of Synaptologics BV)
PO Box 71033
1008 BA Amsterdam
The Netherlands
phone: +31 (0)20 59 83 555
phone: +31 (0)6 42 26 55 14 (mobile)
email: info@sylics.com
www.sylics.com

Sponsors & Partners

Beactica AB (Sweden)

Brainwave-Discovery Ltd. (UK)

Charite University Medicine Berlin (CHAR)

EMBL-European Bioinformatics Institute (EMBL-EBI)

Institut national de la santé et de la recherché medicale (Inserm)

Karolinska Institutet

Katholieke Universiteit Leuven (VIB)

Max Planck Institute

Max-Delbruck-Centrum (Germany)

Stichting VU-VUMC (Netherlands)

Sylics (Netherlands)

Synome Ltd.

The Institute for Molecular Medicine Finland (FIMM)

University of Copenhagen

University of Edinburgh


Last Updated: 04/15/2016

The Consortia-pedia Catalogue is a living resource, and we are always adding new consortia. Provide information here about your collaboration to apply to be included in the Catalogue.

All the information contained in the Consortia-pedia was collected from publically available sources. Decisions to include or exclude a particular listing from Consortia-pedia were also made on the basis of publically available information and the criteria outlined in the FAQs. This site is intended to be an objective resource for the community, and inclusion does not constitute or imply endorsement, recommendation, or approval by FasterCures or the Milken Institute.